Skip to main content
Fig. 1 | Journal of Pharmaceutical Health Care and Sciences

Fig. 1

From: Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes

Fig. 1

Relationship between CYP3A4 activity and serum clarithromycin or its metabolite concentrations for the initial period. Time course of serum concentrations of clarithromycin (CAM, ○), 14-hydroxy-CAM (M-5, △), and urinary 6β-hydroxycortisol/cortisol (6βOHF/F, ♦) ratio up to day 29 (n = 9, mean ± SE). *P <0.05 compared with each initial value

Back to article page